Trxade Group with ticker code (MEDS) have now 3 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The target price ranges between 15 and 9.5 calculating the mean target price we have 12.17. Given that the stocks previous close was at 5.33 this would indicate that there is a potential upside of 128.3%. There is a 50 day moving average of 5.12 while the 200 day moving average is 5.74. The market cap for the company is $42m. You can visit the company’s website by visiting: http://www.trxadegroup.com
Trxade Group, together with its subsidiaries, owns and operates a business-to-business (B2B) web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade; Community Specialty Pharmacy, LLC; Integra Pharma, LLC; and Other segments. The company operates a web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a web-based pharmaceutical marketplace; InventoryRx.com, a web-based pharmaceutical exchange platform; Pharmabayonline that provides proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis to the United States-based independent pharmacies and pharmaceutical databases; and RxGuru, an application, which offers product information. The company also operates a retail specialty pharmacy. In addition, it operates Delivmeds.com, a consumer-based app to provide delivery of pharmaceutical products; Trxademso.com to assist independent retail pharmacies on pricing, distribution, and logistics; and Bonum+, a B2B platform to purchase COVID-19 risk assessment and personal protective equipment tools. Trxade Group is based in Land O’Lakes, Florida.